European Companies Search Engine
CxO: Nicola Rubenstein · ppa (2) · Control: PNC GmbH · Change of legal form: Dr. Osypka GmbH · Address · Capital: €512,000 · Proxy policy … Hrb9 Aug 2010 German Trade Register Announcements, Germany (05/08/2010)
Overview
Text
OSYPKA AG,
Rheinfelden Baden, Earl-H.-Wood-Straße 1, 79618 Rheinfelden
Baden. AG. Articles of Association of June 21, 2010. Business address: Earl-H.-
Unnamed street ??, 79618 Rheinfelden, Germany
Baden. Subject: research, development, manufacture and distribution of electronic devices, measuring and therapy equipment, artificial organ replacement, medical devices, catheters, medical implants and data processing equipment, as well as all related activities. Share capital: EUR 512,000.00. General representation regulation: If only one member of the Board of Management is appointed, he alone represents it. If several members of the Board of Management have been appointed, two represent jointly or one member of the Board of Management with one authorized representative. Individual power of representation may be granted. The members of the Board of Management may be exempted from the restrictions of Section 181 2. Alternative BGB in general. Board of Directors: Dr. Rubenstein, Nicola, née <strike>??????</strike>, Basel (Switzerland), *??.??.????, authorized to represent one another. Overall prokura together with a member of the Board of Management or another authorized representative: ?????, ????????, Maulburg, *??.??.????; ????????, ???????, Schopfheim, *??.??.????. The company was created by the changing form of the GmbH "Dr. Osypka GmbH", Rheinfelden Baden (Amtsgericht Freiburg HRB 410669) in accordance with Section 190 ff. UmwG. With the "PNC GmbH", Rheinfelden (Amtsgericht Freiburg HRB 412559), a profit transfer agreement was concluded on November 25, 2002, which was approved by the shareholders' meeting of the Dr. Osypka GmbH on November 25, 2002. Reference is made to the documents submitted to the court (company contract and consent decisions). By virtue of the Articles of Association, the Management Board is authorised, with the consent of the Supervisory Board, to increase the company's share capital by up to EUR 256,000.00 once or several times against cash or in-interest contributions within five years of this registration. (Authorised capital 2010 I). As not registered: the creditors of the legal entity involved in the change of form must be declared in writing if, within six months of the date on which the entry of the change of form in the register of the registered office of the entity of which they are creditors is deemed to be disclosed in writing, they shall, in accordance with § 19 Abs. 3 UmwG, declare their claim on the basis of reason and amount in writing, unless they can claim satisfaction. However, creditors are only entitled to this right if they demonstrate that the change of form jeopardises the fulfilment of their claim.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: OSYPKA GmbH, Rheinfelden (Baden), Germany.
The visualizations for "OSYPKA AG - CxO: Nicola Rubenstein · ppa (2) · Control: PNC GmbH · Change of legal form: Dr. Osypka GmbH · Address · Capital: €512,000 · Proxy policy …"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
